Protalix BioTherapeutics (PLX) EBIT (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 553.97% |
| Dec 31, 2025 | -318.58% |
| Sep 30, 2025 | 81.83% |
| Jun 30, 2025 | 128.28% |
| Mar 31, 2025 | -157.50% |
| Dec 31, 2024 | 80.63% |
| Sep 30, 2024 | 264.44% |
| Jun 30, 2024 | 50.02% |
| Mar 31, 2024 | 13.52% |
| Dec 31, 2023 | -197.56% |
| Sep 30, 2023 | -109.24% |
| Jun 30, 2023 | 930.46% |
| Mar 31, 2023 | 1.44% |
| Dec 31, 2022 | 20.16% |
| Sep 30, 2022 | 43.43% |
| Jun 30, 2022 | -195.40% |
| Mar 31, 2022 | 67.23% |
| Dec 31, 2021 | -202.71% |
| Sep 30, 2021 | 79.43% |
| Jun 30, 2021 | -147.40% |